Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Optimus Healthcare Svcs's EV-to-EBIT or its related term are showing as below:
OHCS's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 15.87 * Ranked among companies with meaningful EV-to-EBIT only.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Optimus Healthcare Svcs's Enterprise Value for the quarter that ended in Sep. 2024 was $12.45 Mil.
Optimus Healthcare Svcs's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optimus Healthcare Svcs EV-to-EBIT Related Terms
Optimus Healthcare Svcs EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Optimus Healthcare Svcs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimus Healthcare Svcs EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optimus Healthcare Svcs's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Optimus Healthcare Svcs's EV-to-EBIT falls into.
Optimus Healthcare Svcs's current Enterprise Value is $6.67 Mil.
Optimus Healthcare Svcs's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optimus Healthcare Svcs (OHCS) has a EV-to-EBIT of -1.20 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Optimus Healthcare Svcs and its competitors.
Is Optimus Healthcare Svcs' EV-to-EBIT too high?
Optimus Healthcare Svcs' current EV-to-EBIT is -1.20.
How does Optimus Healthcare Svcs' EV-to-EBIT compare to FOXO and OTRKQ?
Optimus Healthcare Svcs' EV-to-EBIT of -1.20 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Optimus Healthcare Svcs and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimus Healthcare Svcs's current EV-to-EBIT is -1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimus Healthcare Svcs stock overvalued right now?
Optimus Healthcare Svcs (OHCS) has a current EV-to-EBIT of -1.20. The current EV-to-EBIT is -1.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Optimus Healthcare Svcs (OHCS), the current EV-to-EBIT is -1.20 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Optimus Healthcare Svcs Inc focuses on acquiring controlling interests in healthcare-related businesses. The company is dedicated to advancing access to clinical trial research and simplifying access to vaccines and pharmaceutical products. It currently operates through its portfolio companies, Clinical Research Alliance, Inc. (CRA), and Worker's Health Rx (d/b/a "Vitality Rx"). The vision is to grow by acquiring controlling interests in healthcare-related businesses with products and services that improve healthcare access and outcomes. Optimus aims to empower physicians and patients with information and tools for informed healthcare decisions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OHCS has been successfully added to your 
